Current treatment of hepatitis C virus infection

被引：1

作者：

Lörke, J ^{[1
]}

Avci, A ^{[1
]}

Erhardt, A ^{[1
]}

Heintges, T ^{[1
]}

Häussinger, D ^{[1
]}

机构：

[1] Univ Dusseldorf, Med Klin & Poliklin, Klin Gastroenterol Hepatol & Infektiol, D-40225 Dusseldorf, Germany

来源：

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2005年 / 130卷 / 30期

关键词：

D O I：

10.1055/s-2005-871894

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1773 / 1777

页数：5

共 31 条

[1] DIAGNOSIS OF HEPATITIS-C - FACTS AND PERSPECTIVES [J].

ALBERTI, A .

JOURNAL OF HEPATOLOGY, 1991, 12 (03) :279-282

[2] Treatment of patients with hepatitis C and normal serum aminotransferase levels [J].

Bacon, BR .

HEPATOLOGY, 2002, 36 (05) :S179-S184

[3] Triple therapy with amantadine in treatment-naive patients with chronic hepatitis C: A placebo-controlled trial [J].

Berg, T ;

Kronenberger, B ;

Hinrichsen, H ;

Gerlach, T ;

Buggisch, P ;

Herrmann, E ;

Spengler, U ;

Goeser, T ;

Nasser, S ;

Wursthorn, K ;

Pape, GR ;

Hopf, U ;

Zeuzem, S .

HEPATOLOGY, 2003, 37 (06) :1359-1367

[4] A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus-infected patients awaiting liver transplantation [J].

Crippin, JS ;

McCashland, T ;

Terrault, N ;

Sheiner, P ;

Charlton, MR .

LIVER TRANSPLANTATION, 2002, 8 (04) :350-355

[5] Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C [J].

Davis, GL ;

Wong, JB ;

McHutchison, JG ;

Manns, MP ;

Harvey, J ;

Albrecht, J .

HEPATOLOGY, 2003, 38 (03) :645-652

[6] Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C [J].

Davis, GL ;

Esteban-Mur, R ;

Rustgi, V ;

Hoefs, J ;

Gordon, SC ;

Trepo, C ;

Shiffman, ML ;

Zeuzem, S ;

Craxi, A ;

Ling, MH ;

Albrecht, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (21) :1493-1499

[7] Iron as comorbid factor in chronic hepatitis C [J].

Erhardt, A ;

Hauck, K ;

Häussinger, D .

MEDIZINISCHE KLINIK, 2003, 98 (12) :685-691

[8] Combination treatment of IFNα2b and ribavirin in patients with chronic hepatitis C and persistently normal ALTs [J].

Erhardt, A ;

Behlen-Wilm, U ;

Adams, O ;

Donner, A ;

Heintges, T ;

Häussinger, D .

DIGESTIVE DISEASES AND SCIENCES, 2003, 48 (05) :921-925

[9] HFE mutations and chronic hepatitis C:: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis [J].

Erhardt, A ;

Maschner-Olberg, A ;

Mellenthin, C ;

Kappert, G ;

Adams, O ;

Donner, A ;

Willers, R ;

Niederau, C ;

Häussinger, D .

JOURNAL OF HEPATOLOGY, 2003, 38 (03) :335-342

[10] Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantation [J].

Forns, X ;

García-Retortillo, M ;

Serrano, T ;

Feliu, A ;

Suarez, F ;

de la Mata, M ;

García-Valdecasas, JC ;

Navasa, M ;

Rimola, A ;

Rodés, J .

JOURNAL OF HEPATOLOGY, 2003, 39 (03) :389-396

← 1 2 3 4 →